Use of human intravenous immunoglobulin in lower motor neuron syndromes

Journal of Neurology Neurosurgery and Psychiatry

Volumn 67, Issue 1, 1999, Pages 15-19

  Ellis, C M ^a,b   Leary, S ^a   Payan, J ^a   Shaw, C ^a   Hu, M ^a   O'Brien, M ^a   Leigh, P N ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Intravenous immunoglobulin; Lower motor neuron; Multifocal motor neuropathy

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ELECTROPHYSIOLOGY; FEMALE; GRIP STRENGTH; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOTOR NEUROPATHY; MUSCLE ATROPHY; MUSCLE STRENGTH; MUSCLE WEAKNESS; NERVE BLOCK; PATIENT SELECTION; PRIORITY JOURNAL; TREATMENT INDICATION; VITAL CAPACITY;

EID: 0033038070     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.67.1.15     Document Type: Article

References (17)

1. Van den Berg LH, Kerkhoff H, Oey PL, et al. Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulin: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1995;59:248-52.
2. Bouche P, Moulonguet A, Younes-Chennoufi AB, et al. Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry 1995;59: 38-44.
3. Van den Berg LH, Franssen H, Wokke JHJ. Improvement of multifocal motor neuropathy during long term weekly treatment with human immunoglobulin. Neurology 1995; 45:987-8.
4. Cornblath DR, Asbury AK, Albers JW, et al, for Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-18.
5. Lange DJ, Trojaborg W, Latov N, et al. Multifocal motor neuropathy with conduction block: is it a distinct clinical entity? Neurology 1992;42:497-505.
6. Katz JS, Wolfe GI, Bryan WW, et al. Electrophysiological findings in multifocal motor neuropathy. Neurology 1997; 48:700-7.
7. Van den Berg LH, Franssen H, Van Doorn PA, et al. Intravenous immunoglobulin treatment in lower motor neuron disease associated with highly raised anti-GM1 antibodies. J Neurol Neurosurg Psychiatry 1997;63:674-7.
8. Azulay J-Ph, Rihet P, Pouget J, et al. Long term follow up of multifocal motor neuropathy with conduction block under treatment. J Neurol Neurosurg Psychiatry 1997;62:391-4.
9. Sewell WAC, Brennan VM, Donaghy M, et al. The use of self infused immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathies. J Neurol Neurosurg Psychiatry 1997;63:106-9.
10. Parry GJ. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve 1994; 17:97-9.
11. Van Schaik IN, Bossuyt PM, Brand A, et al. Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: a meta-analysis. Neurology 1995;45:1570-7.
12. Pestronk A, Choksi R, Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates. Neurology 1997;49:1289-92.
13. Thompson N, Choudhary P, Hughes RAC, et al. A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 1996;243:280-5.
14. Bohannon RW. Test-retest reliability of hand held dynamometry during a single session of strength assessment. Phys Ther 1986;66:206-9.
15. Lennon SM, Ashburn A. Use of myometry in the assessment of neuropathic weakness: testing for reliability in clinical practice. Clin Rehabil 1993;7:125-33.
16. Dailey AT, Tsuruda JS, Goodkin R, et al, Magnetic resonance neurography for cervical radiculopathy: a preliminary report. Neurosurgery 1996;38:488-92.
17. Schady W, Goulding PJ, Lecky BRF, et al. Massive nerve root enlargement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1996;61: 636-40.